Clover Health Investments, Corp.
CLOV
$2.00
-$0.07-3.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -98.91% | 36.18% | 65.16% | 84.30% | 79.84% |
| Total Depreciation and Amortization | 26.67% | -3.07% | -17.88% | -41.95% | -46.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.83% | 482.88% | 8,059.43% | 759.14% | 55.66% |
| Change in Net Operating Assets | -754.97% | -217.74% | 12.71% | -10.64% | -49.17% |
| Cash from Operations | -292.09% | 38.42% | 77.33% | 96.27% | 124.09% |
| Capital Expenditure | -31.30% | -80.25% | -78.81% | -66.58% | -166.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 188.50% | -54.53% | -58.63% | -98.85% | -98.49% |
| Cash from Investing | 621.42% | -56.07% | -60.09% | -99.78% | -99.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 101.11% | 671.31% | 3,167.27% | 269.87% | -21.57% |
| Repurchase of Common Stock | -202.24% | -329.62% | -454.48% | -610.32% | -193.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -207.49% | -322.70% | -438.51% | -626.66% | -242.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -744.04% | -53.48% | 52.10% | 18.79% | 285.71% |